CIK 0001401667 · Accelerated filer<br>Smaller reporting company
PUMA BIOTECHNOLOGY, INC.
Sign in to watch- Ticker
- PBYI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770683487
- Phone
- (424) 248-6500
- Business address
- 10880 WILSHIRE BLVD., SUITE 1700, LOS ANGELES, CA
- Former names
- INNOVATIVE ACQUISITIONS CORP
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- 3 Insider Initial Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- UPLOAD Other SEC-generated Letter
- CT ORDER Other Confidential Order
- 8-K Event Executive or director change
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K/A Event Material agreement · Acquisition or sale completed · Unregistered share sale · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Shell status change
- 8-K Event Material agreement
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · Unregistered share sale
- 4 Insider Changes in Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K/A Event Exhibits
- 10-Q Report Quarterly Report
Page 54 of 57 · 1,125 filings